Commodore Capital LP

Holdings History for Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN)

Symbol: VRDN on Nasdaq
Investment type: Equity / Common Stock, $0.01 par value
Latest Disclosed Shares Owned: 3,200,000 shares
Security Ownership %: 3.9%

Shares, Excluding Options vs Price

Value, Excluding Options

Commodore Capital LP ownership in Viridian Therapeutics, Inc.\DE Common Stock, $0.01 par value (VRDN)

14 Nov 2025 - Commodore Capital LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,200,000 shares of Viridian Therapeutics, Inc.\DE Common Stock, $0.01 par value (VRDN). This represents 3.9% ownership of the company. In their previous filing dated 11 Apr 2025, Commodore Capital LP had reported owning 4,300,000 shares, indicating a decrease of +26%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Commodore Capital LP	3.9%	-28%	$69,056,000	3,200,000	-1,100,000	-26%	$21.58	13G/A	30 Sep 2025	14 Nov 2025, 17:17
Commodore Capital LP	5.3%		$50,697,000	4,300,000			$11.79	13G	04 Apr 2025	11 Apr 2025, 17:15

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025	3.4%	-1.8%	$69,056,000	3,200,000	-1,675,000	-34%	$21.58	Q3 2025
30 Jun 2025	4.8%	+1.3%	$68,152,500	4,875,000	+1,275,000	+35%	$13.98	Q2 2025
31 Mar 2025	3.6%	+1.2%	$48,528,000	3,600,000	+1,200,000		$13.48	Q1 2025
31 Dec 2024	3.4%	-0.21%	$46,008,000	2,400,000	-150,124	-5.9%	$19.17	Q4 2024
30 Sep 2024	3.6%	+0.03%	$58,015,321	2,550,124	+22,092	+0.87%	$22.75	Q3 2024
30 Jun 2024	2.2%	+0.53%	$32,889,696	2,528,032	+593,379	+31%	$13.01	Q2 2024
31 Mar 2024	2.3%	+0.02%	$33,875,774	1,934,653	+10,579	+0.55%	$17.51	Q1 2024
31 Dec 2023	3.7%	-0.72%	$41,906,332	1,924,074	-275,926	-13%	$21.78	Q4 2023
30 Sep 2023	3.9%	0%	$33,748,000	2,200,000	0		$15.34	Q3 2023
30 Jun 2023	5.9%	+0.03%	$52,338,000	2,200,000	+10,341	+0.47%	$23.79	Q2 2023
31 Mar 2023	8.5%	+0.66%	$55,704,925	2,189,659	+169,493	+8.4%	$25.44	Q1 2023
31 Dec 2022	8.9%	-3%	$59,009,000	2,020,166	-676,174	-25%	$29.21	Q4 2022
30 Sep 2022	9.2%	+3.6%	$55,302,000	2,696,340	+1,057,731	+65%	$20.51	Q3 2022
30 Jun 2022	4%	+1.7%	$18,959,000	1,638,609	+687,270	+72%	$11.57	Q2 2022
31 Mar 2022	3.9%	+0.43%	$17,590,000	951,339	+103,656	+12%	$18.49	Q1 2022
31 Dec 2021	3.9%	+0.82%	$16,759,000	847,683	+180,009	+27%	$19.77	Q4 2021
30 Sep 2021	2.9%	+2.8%	$10,983,000	667,674	+481,269	+258%	$16.45	Q3 2021
30 Jun 2021	1.2%	+0%	$3,409,000	186,405	+624	+0.34%	$18.29	Q2 2021
31 Mar 2021	1.2%	+1.7%	$3,104,000	185,781	+185,781	NEW	$16.71	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.